Posted by Michael Wonder on 09 Mar 2017
Submission to Senate Inquiry seeks support for TGA Bill
9 March 2017 - AusBiotech had made a submission to the Senate Inquiry on the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016, urging that the Bill be supported to enable regulatory reform measures stemming from the review of Medicines and Medical Devices Regulation.
AusBiotech supports the Medicines and Medical Devices Regulation’s regulatory reforms and efforts to reduce costs and administrative burden for industry, making the assessment process shorter and simpler, while maintaining the safety and quality of medicines and medical devices.
The Review’s recommendations that won Government support were sensible and supported by stakeholders – from consumers to industry - and are expected to provide industry with annual savings of around $75 million through the reduction in unnecessary red tape and regulation on the pharmaceutical and medical device industries, while maintaining safety and integrity of the regulatory process.
